To probe whether differential CD99 expression could still be of relevance in the animal model of MS, for example by influencing BBB transmigration, we performed an EAE by active immunization against MOG35-55 peptide with these animals for 30 days. This evidence concerns the gene CD99 and myeloid sarcoma.